image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Secondary Recommendation

Concateno - New shell from Marwyn Capital

May 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • COT
  • Price:
  • 125p
The rapturous reception for new AIM shell, Concateno, whose shares at one point shot up 40% since their debut on 7 April, lies in investors' belief that its principal backers will be able to quickly replicate the success of their previous AIM shells, Augean and Zetar. Under the guiding hand of Chairman David Williams and financial adviser Marwyn Capital, both these companies have been injected with high quality growth businesses, resulting in their shares gaining 88% and 210% respectively. Williams and Marwyn have now combined again at Concateno, which has been established to acquire and manage water businesses in the UK and international markets. Concateno raised a net £4.65m from the issue of 5m new shares at 100 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Concateno - Fast growing drug screening provider eyes more deals (July 2007)
Concateno - Fast growing provider of drug screening services (June 2007)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X